Importer of Controlled Substances Application: Wedgewood Village Pharmacy, LLC, 53789-53790 [2022-18927]
Download as PDF
<![CDATA[
jspears on DSK121TN23PROD with NOTICES
Federal Register / Vol. 87, No. 169 / Thursday, September 1, 2022 / Notices
International Trade Commission on July
29, 2022, under section 337 of the Tariff
Act of 1930, as amended, on behalf of
Zodiac Pool Systems LLC of Carlsbad,
California and Zodiac Pool Care Europe
of France. A supplement to the
complaint was filed on August 11, 2022.
The complaint, as supplemented,
alleges violations of section 337 based
upon the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain robotic pool
cleaners and components thereof by
reason of the infringement of certain
claims of U.S. Patent No. 8,393,029
(‘‘the ’029 patent’’) and U.S. Patent No.
8,393,031 (‘‘the ’031 patent’’). The
complaint, as supplemented, further
alleges that an industry in the United
States exists as required by the
applicable Federal Statute.
The complainants request that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
Addresses: The complaint, except for
any confidential information contained
therein, may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Jessica Mullan, Office of Docket
Services, U.S. International Trade
Commission, telephone (202) 205–8264.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2021).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
August 29, 2022, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
VerDate Sep<11>2014
17:15 Aug 31, 2022
Jkt 256001
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of one or more of claims 1,
2, and 7 of the ’029 patent and claims
1–4 of the ’031 patent, and whether an
industry in the United States exists as
required by subsection (a)(2) of section
337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘robotic pool cleaners
and components thereof (chargers,
retrieving hooks, filter baskets, floating
blocks, and roller brushes)’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
Zodiac Pool Systems LLC, 2882
Whiptail Loop East, #100, Carlsbad,
CA 92010
Zodiac Pool Care Europe, ZA La Balme,
31450 Belberaud, France
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Wybotics Co. Ltd. d/b/a Winny Pool
Cleaner, f/k/a Tianjin Wangyuan,
Environmental Protection and
Technology Co., Ltd., No. 30 4th
Street Zong Nan, West Zone Teda,
Tianjin, China 300462
Tianjin Pool & Spa Corporation 2701–
2711 Garfield Avenue, Commerce, CA
90040
Shenzhen Aiper Intelligent Co., Ltd.,
Units 3201, 3203A, and 3205, Block
C, Phase 2 Galaxy World, Minle
Community Minzhi Street, Longhua
District, Shenzhen, Guangdong
Province, China 518129
Aiper Intelligent, LLC, 300 Colonia
Center Parkway, STE 100N, Roswell,
GA 30076
Aiper, Inc., 1429 E 15th Street, Los
Angeles, CA 90021
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in this investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
53789
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainants of
the complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: August 29, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022–18911 Filed 8–31–22; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1025]
Importer of Controlled Substances
Application: Wedgewood Village
Pharmacy, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Wedgewood Village
Pharmacy, LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 3, 2022. Such
persons may also file a written request
for a hearing on the application on or
before October 3, 2022.
DATES:
E:\FR\FM\01SEN1.SGM
01SEN1
53790
Federal Register / Vol. 87, No. 169 / Thursday, September 1, 2022 / Notices
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
RegisterRepresentative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on April 25, 2022,
Wedgewood Village Pharmacy, LLC,
7631 E Indian School Road, Suite 201,
Scottsdale, Arizona 85251–3607,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
jspears on DSK121TN23PROD with NOTICES
Etorphine HCL ..............
Thiafentanil ...................
Drug
code
Schedule
9059
9729
II
II
The company plans to import the
listed controlled substances for
distribution to its customers.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–18927 Filed 8–31–22; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:15 Aug 31, 2022
Jkt 256001
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[NOTICE: 22–067]
Name of Information Collection:
Identity Management System (IdMAX)
for Personal Identity Validation (PIV)
for Routine and Intermittent Access to
NASA Facilities, Sites, and Information
Systems
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of information collection.
AGENCY:
The National Aeronautics and
Space Administration, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections.
DATES: Comments are due by October
31, 2022.
ADDRESSES: Written comments and
recommendations for this information
collection should be sent within 60 days
of publication of this notice to
www.reginfo.gov/public/do/PRAMain.
Find this information collection by
selecting ‘‘Currently under 60-day
Review-Open for Public Comments’’ or
by using the search function.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
instrument(s) and instructions should
be directed to Claire Little, NASA
Clearance Officer, NASA Headquarters,
300 E Street SW, JF0000, Washington,
DC 20546, 202–358–2375, or email
claire.a.little@nasa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Abstract
Homeland Security Presidential
Directive 12 (HSPD–12) established a
mandatory requirement for a
Government-wide identify verification
standard. In compliance with HSPD–12
and the National Institute of Standards
and Technology (NIST) Federal
Information Processing Standard (FIPS)
201: Personal Identity Verification of
Federal Employees and Contractors, and
OMB Policy memorandum M–05–24
Implementation of Homeland Security
Presidential Directive 12, NASA must
collect information from members of the
public to: (1) validate identity and (2)
issue secure and reliable federal
credentials to enable access to NASA
facilities/sites and NASA information
systems. Information collected is
consistent with background
investigation data to include but not
limited to name, date of birth,
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
citizenship, social security number
(SSN), address, employment history,
biometric identifiers (e.g., fingerprints),
signature, digital photograph.
NASA collects information from U.S.
Citizens requiring access 30 or more
days in a calendar year. NASA also
collects information from foreign
nationals regardless of their affiliation
time.
NASA collects, stores, and secures
information from individuals identified
above in the NASA Identify
Management System (IdMAX) in a
manner consistent with the Constitution
and applicable laws, including the
Privacy Act (5 U.S.C. 552a.).
Information is collected via a
combination of electronic and paper
processes and stored in the NASA
Identify Account Exchange (IdMAX)
System.
II. Methods of Collection
Electronic (90%) and paper (10%).
III. Data
Title: Identity Management System
(IdMAX) for Personal Identity
Validation (PIV) for Routine and
Intermittent Access to NASA Facilities,
Sites, and Information Systems.
OMB Number: 2700–0158.
Type of review: Extension without
change of a currently approved
information collection.
Affected Public: Individuals..
Estimated Annual Number of
Activities: 52,000.
Estimated Number of Respondents
per Activity: 1.
Annual Responses: 52,000.
Estimated Time per Response: 10
minutes.
Estimated Total Annual Burden
Hours: 8,667 hours.
Estimated Total Annual Cost:
$800,000.
IV. Request for Comments
Comments are invited on: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of NASA, including
whether the information collected has
practical utility; (2) the accuracy of
NASA’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including automated
collection techniques or the use of other
forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the request for OMB
E:\FR\FM\01SEN1.SGM
01SEN1
]]>Agencies
[Federal Register Volume 87, Number 169 (Thursday, September 1, 2022)]
[Notices]
[Pages 53789-53790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18927]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1025]
Importer of Controlled Substances Application: Wedgewood Village
Pharmacy, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Wedgewood Village Pharmacy, LLC has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 3, 2022. Such persons may also file a written request for a
hearing on the application on or before October 3, 2022.
[[Page 53790]]
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal RegisterRepresentative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on April 25, 2022, Wedgewood Village Pharmacy, LLC, 7631
E Indian School Road, Suite 201, Scottsdale, Arizona 85251-3607,
applied to be registered as an importer of the following basic
class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Etorphine HCL.......................... 9059 II
Thiafentanil........................... 9729 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
distribution to its customers.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-18927 Filed 8-31-22; 8:45 am]
BILLING CODE P
